BridgeBio Pharma, Inc. (BBIO)
66.13
-3.53
(-5.07%)
USD |
NASDAQ |
May 15, 16:00
66.18
+0.05
(+0.08%)
Pre-Market: 09:21
BridgeBio Pharma EPS Diluted (Quarterly) : -0.8422 for March 31, 2026
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Mirum Pharmaceuticals, Inc. | -13.43 |
| Pfizer Inc. | 0.4688 |
| Insmed, Inc. | -0.7591 |
| Alnylam Pharmaceuticals, Inc. | 1.508 |
| Vanda Pharmaceuticals, Inc. | -0.8168 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -166.56M |
| Revenue (Quarterly) | 194.52M |
| Total Expenses (Quarterly) | 358.56M |
| Enterprise Value | 15.41B |
| Gross Profit Margin (Quarterly) | 94.64% |
| Profit Margin (Quarterly) | -85.63% |
| Earnings Yield | -5.66% |
| Normalized Earnings Yield | -5.648 |